Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Punjab: Tribunal Slaps Rs 5 Crore Interim Fine on Pharma Unit for Violations

Farhat Nasim23 Nov 2024 1:27 PM IST

The NGT bench also directed the PSPCB to initiate criminal proceedings against the pharma unit for past violations

Torrent Pharma Receives USFDA Clearance for Pithampur Facility with VAI Classification

Farhat Nasim23 Nov 2024 12:49 PM IST

Mumbai: Torrent Pharmaceuticals Limited has announced that the company received an Establishment Inspection Report (EIR) from the United States...

ASCI Flags 233 Health Ads for DMR Act Violation, Reports to AYUSH Ministry

GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report

Farhat Nasim22 Nov 2024 5:40 PM IST

New Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...

Marksans Pharma arm Relonchem gets Marketing Authorization for Sennosides Tablets in UK

Marksans Pharma Secures USFDA Nod for Generic Version of Clartin Tablet

Farhat Nasim22 Nov 2024 3:03 PM IST

Marksans' product, Loratadine Tablets USP 10 mg are indicated for the treatment of allergic rhinitis.

Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief

Farhat Nasim22 Nov 2024 2:41 PM IST

Chris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & development across all...

After Manipal Hospitals, PMC warns all private hospitals against withholding dead bodies over unpaid bills

Unexo Lifesciences Faces USFDA Heat Over Serious CGMP Violations

Farhat Nasim22 Nov 2024 2:13 PM IST

In response to the issues, the USFDA recommended a voluntary recall of all drug products manufactured at Unexo's facility for the U.S. market.

Wockhardt Founder Seeks GST Exemption on India-Discovered Antibiotics to Enhance Affordability

Farhat Nasim22 Nov 2024 1:19 PM IST

At an event celebrating India's first indigenously developed antibiotic, Nafithromycin, Khorakiwala highlighted the disparity in GST.

Jazz Pharma's Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract Cancer

Farhat Nasim22 Nov 2024 12:30 PM IST

The drug zanidatamab-hrii, sold under the brand name Ziihera, is approved for use in previously treated adults with metastatic HER2-positive biliary...

Cipla exploring new customer deals for its China factory: Executive

Setback to Cipla: DoP rejects plea challenging NPPA order for Acivir Tablets pricing

Farhat Nasim21 Nov 2024 6:16 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg...

Alloy Therapeutics collaborates with Pfizer to develop new antibody discovery platform

Pfizer's HYMPAVZI gets European Commission Approval to Treat Severe Hemophilia A and B

Farhat Nasim21 Nov 2024 3:26 PM IST

Delhi: Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab) for the routine...

Strides Pharma Secures NCLT Approval for OneSource, India's First Specialty Pharma CDMO

Farhat Nasim21 Nov 2024 1:56 PM IST

Mumbai: Strides Pharma Science Limited, on Tuesday, announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved its Scheme of...

Cipla Recalls Lanthanum Carbonate Tablets in US

Farhat Nasim21 Nov 2024 1:38 PM IST

As per the USFDA, New Jersey based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok